Osimertinib vs Trastuzumab Emtansine

## Osimertinib vs Trastuzumab Emtansine: Overview

This comparison examines the pharmacological differences between **Osimertinib** and **Trastuzumab Emtansine**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Osimertinib — 48 hours; Trastuzumab Emtansine — N/A.

## Chemical Properties

**Molecular Formula**: Osimertinib — C28H33N7O2; Trastuzumab Emtansine — N/A.

**Molecular Weight**: Osimertinib — 499.6050 g/mol; Trastuzumab Emtansine — N/A.

**Type**: Osimertinib — Small molecule; Trastuzumab Emtansine — Antibody drug conjugate.